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 The resistance of the brain to defi cient blood supply 
can increase in response to brief episodes of ischemia-reper-
fusion or hypoxia [1], transient hypothermia [2], or other 
moderate stressors able to activate endogenous defense 
mechanisms and increase tissue resistance to subsequent 
severe ischemia [3–5]. This phenomenon is termed pre-
conditioning. Activation of adenosine triphosphate-depen-
dent potassium (K+ATP) channels is regarded as the main 
component of responses in models of preconditioning [3]. 
Decreases in ATP levels during ischemia lead to opening of 
K+ATP channels in the plasma membrane; the role of these 
channels is to restore low concentrations of Na+ and Ca2+ 
ions in the cytosol and prevent depolarization. Activation 
of K+ATP channels in the inner mitochondrial membrane is 
associated with protecting mitochondria against Ca2+ ion 
overload [6]. The leading role in the development of pre-
conditioning is played by the mitochondrial pool [7].
 The role of nitric oxide (NO) in the development of 
ischemic cell damage is just as important. The nature of the 
action of NO depends on the intensity and location of its 
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Objective. The role of ATP-dependent potassium (K+ATP) channels in the neuroprotective effect of ischemic 
(IPre) and pharmacological (PPre) preconditioning and changes in blood levels of nitric oxide (NO) metab-
olites were studied in conditions of cerebral ischemia. Materials and methods. Ischemic stroke (IS) was 
modeled in male rats (n = 86) by electrocoagulation of a branch of the middle cerebral artery (MCA). The 
nonselective K+ATP channel blocker glibenclamide and the K+ATP channel activator diazoxide were used. IPre 
and PPre were performed one day before MCA occlusion. Blood concentrations of NO, nitrates (NO3–) and 
nitrites (NO2–) were determined in experimental animals at 5, 24, and 72 h after MCA occlusion. Results. 
IPre decreased the lesion zone by 37% (p < 0.05), while prior administration of glibenclamide countered 
the action of IPre. The protective effect of PPre was analogous to that of IPre. Decreases in blood levels of 
oxygenated R-conformers of hemoglobin-bound NO (Hb-NO) were seen 5 h after MCA occlusion, with 
an inversely proportional increase in the concentration of nonoxygenated T-conformers; there were also 
increases in NO3– and NO2– concentrations. NO3– and NO2– levels showed normalization by one day after 
MCA occlusion, along with changes in the concentrations of Hb-NO complexes – R-conformers dominated, 
while the blood level of T-conformers reached a minimum. Furthermore, by 24 h there was a correlation 
between blockade of K+ATP channels and decreases in serum NO3– and NO2– levels (p < 0.03). Conclusions. 
The neuroprotective effect of preconditioning was due to activation of K+ATP channels. Analysis of blood 
levels of NO metabolites in rats with IS showed that Hb-NO complexes in the R-conformation stored and 
carried NO to the tissues, releasing NO on occurrence of the R → T transition in ischemic conditions.
Keywords: cerebral ischemia, ischemic tolerance, neuroprotection, preconditioning phenomenon, ATP-dependent potassium 
channels, nitric oxide, hemoglobin, spectrophotometry, electron paramagnetic resonance.
1  Lomonosov Moscow State University. Moscow, Russia; 
e-mail: olegderyagin@gmail.com.
2  Kazan Physicotechnical Institute, Kazan Scientifi c Center, 
Russian Academy of Sciences, Kazan, Russia.
3  Institute of Basic Medicine and Biology, Kazan (Volga) Federal 
University, Kazan, Russia.
DOI 10.1007/s11055-017-0530-z
